|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LGF-A | RACHESKY MARK H MD | Director | Nov 16 | Buy | 6.94 | 236,585 | 1,641,758 | 3,479,132 | Nov 18 07:19 PM |
LGF-A | RACHESKY MARK H MD | Director | Nov 17 | Buy | 6.68 | 234,795 | 1,567,609 | 3,713,927 | Nov 18 07:19 PM |
LGF-A | RACHESKY MARK H MD | Director | Nov 18 | Buy | 6.90 | 400,000 | 2,759,640 | 4,113,927 | Nov 18 07:19 PM |
LGF-B | RACHESKY MARK H MD | Director | Nov 16 | Buy | 6.94 | 236,585 | 1,641,758 | 3,479,132 | Nov 18 07:19 PM |
LGF-B | RACHESKY MARK H MD | Director | Nov 17 | Buy | 6.68 | 234,795 | 1,567,609 | 3,713,927 | Nov 18 07:19 PM |
LGF-B | RACHESKY MARK H MD | Director | Nov 18 | Buy | 6.90 | 400,000 | 2,759,640 | 4,113,927 | Nov 18 07:19 PM |
TWI | RACHESKY MARK H MD | Director | Dec 08 | Buy | 10.35 | 210,000 | 2,174,088 | 6,905,427 | Dec 10 06:34 PM |
TWI | RACHESKY MARK H MD | Director | Dec 09 | Buy | 10.55 | 145,000 | 1,530,344 | 7,050,427 | Dec 10 06:34 PM |
TWI | RACHESKY MARK H MD | Director | Dec 10 | Buy | 10.39 | 150,000 | 1,558,365 | 7,200,427 | Dec 10 06:34 PM |
TWI | RACHESKY MARK H MD | Director | Jul 28 | Buy | 14.11 | 250,000 | 3,528,350 | 6,478,309 | Jul 30 07:22 PM |
TWI | RACHESKY MARK H MD | Director | Jul 29 | Buy | 14.92 | 39,603 | 590,857 | 6,514,020 | Jul 30 07:22 PM |
TWI | RACHESKY MARK H MD | Director | Jul 30 | Buy | 15.00 | 201,172 | 3,017,359 | 6,695,427 | Jul 30 07:22 PM |
TWI | RACHESKY MARK H MD | 10% Owner | Apr 25 | Buy | 16.68 | 260,000 | 4,336,592 | 5,726,049 | Apr 29 07:01 PM |
TWI | RACHESKY MARK H MD | 10% Owner | Apr 28 | Buy | 16.38 | 200,000 | 3,275,020 | 5,907,409 | Apr 29 07:01 PM |
TWI | RACHESKY MARK H MD | 10% Owner | Apr 29 | Buy | 16.34 | 382,125 | 6,242,814 | 6,252,872 | Apr 29 07:01 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite